These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8255265)

  • 1. Are evaluations of carcinogenicity by various committees worth comparing?
    Boffetta P; Saracci R; Vainio H; Wilbourn J; Tomatis L
    Med Lav; 1993; 84(4):332-3. PubMed ID: 8255265
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of carcinogenicity classifications and evaluations: the case of formaldehyde.
    Binetti R; Costamagna FM; Marcello I
    Ann Ist Super Sanita; 2006; 42(2):132-43. PubMed ID: 17033133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Decree 626/94, section VII "Protection from carcinogenic agents": comparison of agents tested for evidence of carcinogenicity by the EEC and IARC].
    Fondelli MC; Seniori Costantini A
    Med Lav; 1997; 88(5):356-73. PubMed ID: 9489300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status of the Gene-Tox Program.
    Auletta AE; Kier LD; Mitchell AD
    Prog Clin Biol Res; 1990; 340D():273-81. PubMed ID: 2371300
    [No Abstract]   [Full Text] [Related]  

  • 5. [The definitions and classifications of carcinogenesis, mutagenesis and teratogenesis used by national and international agencies and institutions].
    Mucci N; Rossi L
    Med Lav; 1992; 83(3):211-43. PubMed ID: 1528161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of occupational carcinogens and mutagens.
    Ruder AM
    Occup Med; 1996; 11(3):487-512. PubMed ID: 8887381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Animal studies in potency ranking of carcinogens in Norway.
    Sanner T; Dybing E; Hardeng S; Haug E; Ovrebø S
    Prog Clin Biol Res; 1992; 374():399-414. PubMed ID: 1620715
    [No Abstract]   [Full Text] [Related]  

  • 8. Animal carcinogenicity studies: implications for the REACH system.
    Knight A; Bailey J; Balcombe J
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():139-47. PubMed ID: 16555967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing for carcinogens: shift from animals to automation gathers steam--slowly.
    Schmidt C
    J Natl Cancer Inst; 2009 Jul; 101(13):910-2. PubMed ID: 19549960
    [No Abstract]   [Full Text] [Related]  

  • 10. Classifications for carcinogenesis of antitumoral drugs.
    Binetti R; Costamagna FM; Marcello I
    J Exp Clin Cancer Res; 2003 Dec; 22(4):651-72. PubMed ID: 15053312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Researchers exploring faster alternatives to 2-year test for carcinogenicity.
    Schmidt C
    J Natl Cancer Inst; 2006 Feb; 98(4):228-30. PubMed ID: 16478737
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulatory aspects of carcinogenicity studies and the Delaney clause.
    Flamm WG
    Regul Toxicol Pharmacol; 1995 Feb; 21(1):71-4; discussion 81-6. PubMed ID: 7784638
    [No Abstract]   [Full Text] [Related]  

  • 13. Animal testing and EPA.
    Farland WH; Vaughn-Dellarco V
    Science; 1995 Dec; 270(5244):1907, 1909. PubMed ID: 8533076
    [No Abstract]   [Full Text] [Related]  

  • 14. A classification framework and practical guidance for establishing a mode of action for chemical carcinogens.
    Butterworth BE
    Regul Toxicol Pharmacol; 2006 Jun; 45(1):9-23. PubMed ID: 16530901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Industry efforts to weaken the EPA's classification of the carcinogenicity of 1,3-butadiene.
    Sass JB
    Int J Occup Environ Health; 2005; 11(4):378-83. PubMed ID: 16350472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term tests for defining mutagenic carcinogens.
    Waters MD; Stack HF; Jackson MA
    IARC Sci Publ; 1999; (146):499-536. PubMed ID: 10353401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vinyl chloride and 1,2-dichloroethane: classification and assessment of carcinogenicity, guidelines, threshold values, and standards developed by national and international entities, organizations, and agencies].
    Binetti R; Costamagna FM; Marcello I
    Epidemiol Prev; 2001; 25(1):31-9. PubMed ID: 11296535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determining carcinogenicity.
    Vainio H; Armstrong B; Tomatis L
    Science; 1993 Aug; 261(5123):814-5. PubMed ID: 8240516
    [No Abstract]   [Full Text] [Related]  

  • 19. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective.
    Bolt HM; Foth H; Hengstler JG; Degen GH
    Toxicol Lett; 2004 Jun; 151(1):29-41. PubMed ID: 15177638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Agricultural antiparasitics evaluated for their potential cancerogenic, mutagenic and toxic reproductive effects].
    Petrelli G; Mucci N; Siepi G; Pace F
    Med Lav; 1996; 87(2):110-21. PubMed ID: 8926915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.